Ibrutinib as salvage therapy in mantle cell lymphoma with central nervous system involvement in a pretreated unfit patient.

LEUKEMIA & LYMPHOMA(2018)

引用 3|浏览9
暂无评分
摘要
Mantle cell lymphoma (MCL) accounts for approximately 3–6% of all Non-Hodgkin Lymphomas (NHL). Patients’ median age at diagnosis is 68 years [1] with male predominance and median survival of 4–5 ye...
更多
查看译文
关键词
mantle cell lymphoma,central nervous system involvement
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要